# Bioequivalence Study of Nimesulide 100 mg Tablets

> **NCT01745614** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Nimesulide 100 mg tablets
- **DRUG:** Nimesulide 100 mg tablets

## Key facts

- **NCT ID:** NCT01745614
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-18
- **Primary completion:** 2010-07-26
- **Final completion:** 2010-07-26
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745614, "Bioequivalence Study of Nimesulide 100 mg Tablets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01745614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*